Hematological Toxicity: Biological Basis
A shortage of leukocytes and platelets may be treated by transfusions, as will be discussed by others. A search for a more efficient treatment or prevention of haemopoietic failure after chemotherapy has not yielded a better treatment. Autologous bone marrow transplantation after single high dose cytostatic therapy was not a successful method to combat toxicity. The biological basis of bone marrow toxicity should be studied in more detail to find better means to combat it. A retrospective look for the reason why bone marrow transplantation failed, indicates that stem cell loss was not the cause of death after single dose chemotherapy. Animal studies confirm, that X-ray lethality but not the mortality after chemotherapy may be prevented by stem cell replacement.
KeywordsMethotrexate Cyclophosphamide Cytosine Halothane Vincristine
Bis-Chloro-aethyl Nitroso Urea
Methyl-Cyclohexyl-Chloroethyl Nitroso Urea
- 15 MeVN
15 MeV neutron irradiation
300 keV X-rays.
haemopoietic spleen colony forming stem cell
tritiated thymidine (9 Ci/mMol.)
4-demethyl-epipodophyllotoxin-thenylidene glucoside, supplied by Sandoz
Unable to display preview. Download preview PDF.
- BekkumD. W. van: Foreign bone marrow transplantation following fractionated wholebody irradiation in mice. In: Radiation effects in physics, chemistry and biology, p. 362 (Ed.: M. Ebert and A. Howard), Amsterdam: North Holland Publishing Co. 1963.Google Scholar
- Putten L. M. van, Lelieveld, P., Kram-idsengaL. K. J.: Cell-cycle specificity and therapeutic effectiveness of cytostatic agents. Cancer Chemother. Reports Part 1, 56, 6 (1972).Google Scholar